Scott A. Van Wart, M.S.

Director, Pharmacometrics

Telephone: (518) 429-2600
Fax (518) 429-2601

E-mail: SVanwart@ICPD.com

Research Focus

Over the past 11 years, Scott has collaborated with many pharmaceutical companies to plan and implement pharmacokinetic (PK) and pharmacodynamic (PK-PD) modeling and simulation analyses to support drug development and commercialization programs. Scott has considerable experience helping Sponsors leverage the insight gained from PK and PK-PD analyses to guide decision making at critical development milestones in a variety of therapeutic areas, most notable for infectious and cardiovascular diseases. Scott’s broad range of pharmacometric expertise includes non-compartmental PK analysis, population PK analysis, population PK-PD analysis, including physiologic- and mechanism-based PK-PD modeling, optimal study design, clinical trial simulation, and post-marketing data analysis.

Scott currently holds professional society memberships in the American Association of Pharmaceutical Scientists and the American Society of Clinical Pharmacology and Therapeutics. Scott is the author or co-author of approximately 30 peer-reviewed scientific publications, abstracts, and presentations.

Scott received a B.Sc. in Pharmaceutics and minor in Business Marketing (1996), as well as a M.S. in Pharmacometrics (2004), from the State University of New York at Buffalo. Scott is currently completing a Ph.D. in Pharmaceutical Sciences at the State University of New York at Buffalo, where his focus is on using mechanistic PK-PD modeling and simulation to improve the understanding and treatment of various cardiovascular diseases.